Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2022 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| PRO-CEPHALEXIN | PRO DOC LIMITEE | Marketed | Feb 16, 2026 | Marketed |
| NILEMDO | 海倫司國際控股有限公司 | Marketed | Feb 6, 2026 | Marketed |
| OPSUMIT | Janssen Inc | Marketed | Jan 27, 2026 | Marketed |
| LOQTORZI | Apotex Inc | Marketed | Jan 26, 2026 | Marketed |
| PMS-SACUBITRIL-VALSARTAN | Pharmascience Inc | Marketed | Jan 22, 2026 | Marketed |
| PMS-SACUBITRIL-VALSARTAN | Pharmascience Inc | Marketed | Jan 22, 2026 | Marketed |
| PMS-SACUBITRIL-VALSARTAN | Pharmascience Inc | Marketed | Jan 22, 2026 | Marketed |
| VYVGART SC | ARGENX BV | Marketed | Jan 20, 2026 | Marketed |
| ZDS-LIOTHYRONINE | ZYDUS LIFESCIENCES LIMITED | Marketed | Jan 15, 2026 | Marketed |
| ZDS-LIOTHYRONINE | ZYDUS LIFESCIENCES LIMITED | Marketed | Jan 15, 2026 | Marketed |
| AVTOZMA | Celltrion Inc | Marketed | Jan 14, 2026 | Marketed |
| AVTOZMA | Celltrion Inc | Marketed | Jan 14, 2026 | Marketed |
| AVTOZMA | Celltrion Inc | Marketed | Jan 14, 2026 | Marketed |
| AVTOZMA | Celltrion Inc | Marketed | Jan 14, 2026 | Marketed |
| AVTOZMA | Celltrion Inc | Marketed | Jan 14, 2026 | Marketed |
| CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE | Sterimax Inc | Marketed | Jan 13, 2026 | Marketed |
| HERTEL TOUT USAGE | KIK HOLDCO COMPANY INC. DBA / S/N LAVO | Marketed | Jan 12, 2026 | Marketed |
| FACIAL MOISTURIZING LOTION SPF 50 | CERAVE CANADA | Marketed | Jan 12, 2026 | Marketed |
| HERTEL NETTOYANT MULTI SURFACE | KIK HOLDCO COMPANY INC. DBA / S/N LAVO | Marketed | Jan 12, 2026 | Marketed |
| ELAHERE | Abbvie Corporation | Marketed | Jan 9, 2026 | Marketed |
